HA
HHLR Advisors Portfolio holdings
AUM
$3.1B
This Quarter Return
+5.39%
1 Year Return
+44.54%
3 Year Return
+121.93%
5 Year Return
+166.86%
10 Year Return
–
AUM
$9.71B
AUM Growth
+$9.71B
(-4%)
Cap. Flow
-$725M
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
61.24%
Holding
100
New
9
Increased
6
Reduced
17
Closed
11
Top Buys
| 1 |
Airbnb
ABNB
|
$324M |
| 2 |
Vipshop
VIPS
|
$171M |
| 3 |
Alibaba
BABA
|
$131M |
| 4 |
MINISO
MNSO
|
$111M |
| 5 |
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
|
$42.6M |
Top Sells
| 1 |
Pinduoduo
PDD
|
$422M |
| 2 |
Zoom
ZM
|
$367M |
| 3 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
$351M |
| 4 |
GDS Holdings
GDS
|
$216M |
| 5 |
Apellis Pharmaceuticals
APLS
|
$103M |
Sector Composition
| 1 | Healthcare | 42.52% |
| 2 | Consumer Discretionary | 24.31% |
| 3 | Technology | 11.89% |
| 4 | Communication Services | 10.14% |
| 5 | Financials | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Dyne Therapeutics
DYN
$1.92B
| $21M | 0.22% |
1,000,000
| – | – |
|
52
Allogene Therapeutics
ALLO
$249M
| $20.9M | 0.21% |
800,000
| – | – |
|
53
Keurig Dr Pepper
KDP
$39.5B
| $20.1M | 0.21% |
569,584
-390,570
| -41% | -$13.8M |
|
54
Century Therapeutics
IPSC
$40.4M
| $18M | 0.19% |
+614,095
| New | +$18M |
|
55
Regenxbio
RGNX
$498M
| $17.7M | 0.18% |
456,000
| – | – |
|
56
Olema Pharmaceuticals
OLMA
$432M
| $17.4M | 0.18% |
620,397
| – | – |
|
|
MOGU
57
MOGU Inc
MOGU
$20M
| $17.3M | 0.18% |
10,446,970
| – | – |
|
|
BEDU
58
Bright Scholar Education Holdings
BEDU
$51.4M
| $16.9M | 0.17% |
3,985,797
| – | – |
|
59
Prelude Therapeutics
PRLD
$69.1M
| $16.7M | 0.17% |
583,333
-43,169
| -7% | -$1.24M |
|
60
Snowflake
SNOW
$76.5B
| $15.2M | 0.16% |
63,000
| – | – |
|
|
SOHU
61
Sohu.com
SOHU
$487M
| $14.9M | 0.15% |
802,034
| – | – |
|
62
Kura Oncology
KURA
$732M
| $13.6M | 0.14% |
650,000
| – | – |
|
|
IGMS
63
DELISTED
IGM Biosciences
IGMS
| $12.6M | 0.13% |
151,390
| – | – |
|
64
Tourmaline Bio
TRML
$645M
| $12.5M | 0.13% |
+853,344
| New | +$12.5M |
|
65
ADC Therapeutics
ADCT
$370M
| $12.2M | 0.13% |
500,000
| – | – |
|
66
Immunocore
IMCR
$1.78B
| $10.8M | 0.11% |
277,754
-1,826
| -0.7% | -$71.3K |
|
67
Avidity Biosciences
RNA
$6.12B
| $10.5M | 0.11% |
425,000
| – | – |
|
|
KRON
68
DELISTED
Kronos Bio
KRON
| $10.4M | 0.11% |
433,436
-225,000
| -34% | -$5.39M |
|
69
UiPath
PATH
$5.82B
| $10.2M | 0.1% |
+150,000
| New | +$10.2M |
|
|
MREO
70
Mereo BioPharma
MREO
$275M
| $9.43M | 0.1% |
2,976,121
| – | – |
|
|
UXIN
71
Uxin Ltd
UXIN
$748M
| $8.85M | 0.09% |
2,297,318
| – | – |
|
72
Nkarta
NKTX
$149M
| $8.8M | 0.09% |
277,778
-81,750
| -23% | -$2.59M |
|
73
Cogent Biosciences
COGT
$1.83B
| $8.11M | 0.08% |
1,000,000
| – | – |
|
|
CDAK
74
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
| $6.8M | 0.07% |
366,721
| – | – |
|
75
Leap Therapeutics
LPTX
$12M
| $5.86M | 0.06% |
3,575,745
| – | – |
|